This compound is a pharmaceutical intermediate featuring a tert-butoxycarbonyl-protected amino group and a hydroxyl group on a cyclohexane ring with defined cis stereochemistry. It is primarily used as a building block in the synthesis of more complex pharmaceutical compounds.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 224309-64-2
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for synthesis
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
tert-butyl N-(4-hydroxycyclohexyl)carbamate
DQARDWKWPIRJEH-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CCC(CC1)O